TITAN PHARMACEUTICALS INC 4/A
4/A · TITAN PHARMACEUTICALS INC · Filed Feb 2, 2016
Insider Transaction Report
Form 4/AAmended
BHONSLE SUNIL
DirectorPresident
Transactions
- Award
Option to Purchase Common Stock
2015-12-14+90,900→ 90,900 totalExercise: $5.10Exp: 2025-12-14→ Common Stock (90,900 underlying)
Footnotes (1)
- [F1]The options vest in 24 equal monthly installments commencing on the grant date.